Fantasy Baseball: 2014 Fantasy Outlook for the Biogenesis Five

Use your ← → (arrows) to browse
fantasy baseball

Mandatory Credit: Brad Barr-USA TODAY Sports

In 2014, fantasy drafts are going to have an unprecedented nuance to them.

How do owners assess the value of the big name fantasy baseball players returning from PED suspensions stemming from last year’s Biogenesis scandal?

There is currently no way to scientifically project seasons of players who have been suspended for using performance enhancing drugs.  The sample size of these players is far too small and their achievements before and after the suspensions are all over the map.

In 2012 three players were suspended for PED use:

Melky Cabrera was coming off of a huge breakout season and was in the middle of another big year when he was suspended. Last year Toronto gave him a big contract and he rewarded them a big pile of hot garbage.  He was dinged up all year and saw his OPS against lefties plummet over five hundred points!

Yasmani Grandal, in between the suspension — and season-ending ACL surgery — continued to not live up to his prospect hype.

Bartolo Colon returned to post the lowest ERA of his career and win 18 games on a shockingly good Oakland A’s team.  Then again, who needs PEDs when you can just have stem cell therapy?

Thanks to last year’s Biogenesis scandal, 13 players get smacked with suspensions — the most simultaneous suspensions in baseball history — beating the previous record of eight men out in the 1919 Black Sox scandal.

Let’s take a look at the five fantasy relevant ne’er-do-wells out of the 13 and break down how they’d look on your fantasy roster.

Use your ← → (arrows) to browse

comments powered by Disqus